Product Information

DEXTROAMP-AMPHETAM 12.5 MG TAB is a generic product labeled by NorthStar Rx LLC, priced at $0.3718 per EA under NDC 16714080501. Its NADAC has been published 419 times since Nov 14, 2018.

FDA first approved this application on Sep 9, 2003. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DEA Schedule CII

Strength

3.125; 3.125; 3.125; 3.125 mg/1; mg/1; mg/1; mg/1

Manufacturer

NorthStar Rx LLC

NDC

16714080501

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA040480

FDA Approved

9/9/2003

TE Code

AB

On Market Since

9/9/2003

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulation
Central Nervous System Stimulation
Central Nervous System Stimulation
Central Nervous System Stimulation

Price Statistics

The NADAC for DEXTROAMP-AMPHETAM 12.5 MG TAB has been published 419 times since Nov 14, 2018, and over the history we have for it it has declined 33.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.3718 per EA
All-time high$0.8446 (Feb 12, 2020)
All-time low$0.2862 (Nov 20, 2024)
52-week high$0.3718
52-week low$0.3065
Median price$0.5426
Average price$0.5472
Largest weekly change+70.2% (Dec 21, 2022)
Weeks tracked419
Tracking sinceNov 14, 2018

Price History

1W

+6.0%

1M

+3.5%

3M

+7.9%

6M

+21.3%

1Y

+7.0%

3Y

-28.8%

5Y

-43.7%

All

-33.3%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of DEXTROAMP-AMPHETAM 12.5 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for DEXTROAMP-AMPHETAM 12.5 MG TAB, manufactured by NorthStar Rx LLC, is $0.3718 per EA (NDC 16714080501), effective Nov 18, 2026.

How has the price of DEXTROAMP-AMPHETAM 12.5 MG TAB changed over time?

Over the history we have for it, the NADAC for DEXTROAMP-AMPHETAM 12.5 MG TAB has declined 33.3%. It has been tracked across 419 weekly CMS publications since Nov 14, 2018.

What are the highest and lowest recorded NADAC prices for DEXTROAMP-AMPHETAM 12.5 MG TAB?

Since Nov 14, 2018, the NADAC for DEXTROAMP-AMPHETAM 12.5 MG TAB has ranged from a low of $0.2862 (Nov 20, 2024) to a high of $0.8446 (Feb 12, 2020), with a median of $0.5426 per EA.

Are there cheaper alternatives to DEXTROAMP-AMPHETAM 12.5 MG TAB?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as DEXTROAMP-AMPHETAM 12.5 MG TAB in a comparable dosage form, but none are currently priced below it.

Who manufactures DEXTROAMP-AMPHETAM 12.5 MG TAB?

DEXTROAMP-AMPHETAM 12.5 MG TAB (NDC 16714080501) is labeled by NorthStar Rx LLC, and CMS classifies it as a generic product.